肝硬化患者自发性细菌性腹膜炎一级与二级预防的结局比较
基于北美终末期肝病研究联盟数据,比较305例一级与187例二级自发性细菌性腹膜炎(SBP)预防的肝硬化住院患者,倾向性匹配后每组154例。一级预防组ICU入住率31% vs 21%(P=0.05)、住院死亡率19% vs 9%(P=0.01)、90天死亡率35% vs 22%(P=0.02)及急性肾损伤48% vs 30%(P=0.04)均高于二级预防组;
要点
- 一级预防组住院死亡率19% vs 二级预防组9%(P=0.01)。
- 一级预防组90天死亡率35% vs 二级预防组22%(P=0.02)。
核心结论
- 肝硬化住院患者中,尽管接受预防,仍有高比例发生SBP且与死亡相关;按MELD评分和血清白蛋白倾向性匹配后,一级预防者结局劣于二级预防者。
研究设计与样本
- 北美终末期肝病研究联盟的多中心住院肝硬化患者数据,共纳入2731例,其中305例接受一级预防、187例接受二级预防;按入院MELD评分和血清白蛋白进行倾向性匹配后每组154例,比较住院期间及90天结局。
主要发现
- 匹配后,一级预防组入院时全身炎症反应综合征更常见(P=0.02),ICU入住率31% vs 21%(P=0.05),住院死亡率19% vs 9%(P=0.01)。
- 90天时,一级预防组死亡率35% vs 22%(P=0.02),急性肾损伤发生率48% vs 30%(P=0.04),均高于二级预防组。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Antibiotic prophylaxis is recommended for prevention of the first episode of spontaneous bacterial peritonitis (SBP; primary prophylaxis 1°) and subsequent episodes (secondary prophylaxis 2°). We aimed to compare outcomes in cirrhotic inpatients on 1° vs 2° SBP prophylaxis. METHODS: Data from North American Consortium for the Study of End-Stage Liver Disease were evaluated for cirrhosis details, reasons for admission/medications, inpatient course recorded, and outcomes over 90 days. Outcomes (intensive care units, acute kidney injury, inpatient/90-day mortality) were compared between the 2 groups after propensity-matching on admission model for end-stage liver disease (MELD) score and serum albumin. RESULTS: Among the 2,731 patients enrolled, 305 were on 1° and 187 on 2° SBP prophylaxis. After propensity-matching, 154 patients remained in each group. Patients on 1° prophylaxis were more likely to have admission systemic inflammatory response syndrome (P = 0.02), with higher intensive care unit admissions (31% vs 21%; P = 0.05) and inpatient mortality (19% vs 9%; P = 0.01) than the 2° prophylaxis group. Patients on 2° prophylaxis had higher total (22% vs 10%; P = 0004), readmission (16% vs 9%; P = 0.03), and nosocomial (6% vs 0.5%; P = 0.01) SBP rates with predominant Gram-negative organisms compared to 1° prophylaxis patients. At 90 days, 1° prophylaxis patients had a higher mortality (35% vs 22%; P = 0.02) and acute kidney injury incidence (48% vs 30%; P = 0.04) compared to 2° prophylaxis patients. DISCUSSION: In this inpatient cirrhosis study, despite prophylaxis, a high proportion of patients developed SBP, which was associated with mortality. Cirrhotic inpatients on 1° prophylaxis had worse outcomes than those on 2° prophylaxis when propensity-matched for the MELD score and serum albumin during the index admission and 90-day follow-up.
引用
- Bajaj JS, Tandon P, OʼLeary JG, et al. Outcomes in Patients With Cirrhosis on Primary Compared to Secondary Prophylaxis for Spontaneous Bacterial Peritonitis. Am J Gastroenterol. 2019. PMID: 30694868. doi:10.14309/ajg.0000000000000044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。